Michael Kenison
Corporate Officer/Principal bij PROTO LABS, INC.
Vermogen: 357 340 $ op 30-04-2024
Profiel
Michael R.
Kenison is currently the Vice President & General Manager-Americas at Proto Labs, Inc. He previously worked as the Vice President-Manufacturing at Cardiac Science, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PROTO LABS, INC.
0.04% | 28-03-2024 | 11 373 ( 0.04% ) | 357 340 $ | 30-04-2024 |
Actieve functies van Michael Kenison
| Bedrijven | Functie | Begin |
|---|---|---|
| PROTO LABS, INC. | Corporate Officer/Principal | 01-06-2021 |
Eerdere bekende functies van Michael Kenison
| Bedrijven | Functie | Einde |
|---|---|---|
Cardiac Science, Inc.
 Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PROTO LABS, INC. | Process Industries |
| Bedrijven in privébezit | 1 |
|---|---|
Cardiac Science, Inc.
Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide. | Commercial Services |
